AMANDA RIDENHOUR: Open Payments
NPI 1558540518 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 25 payments from 14 companies in 2025. Trend: 2023 $4,539 · 2024 $2,781 · 2025 $1,582
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $298 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $268 |
| Sequel Med Tech, LLC | 2 | $265 |
| Corcept Therapeutics | 4 | $253 |
| Insulet Corporation | 3 | $168 |
| Amgen Inc. | 2 | $91 |
| Tandem Diabetes Care, Inc. | 1 | $72 |
| Lilly USA, LLC | 2 | $33 |
| Radius Health, Inc. | 1 | $33 |
| Ascensia Diabetes Care Us Inc. | 1 | $26 |
Products named: CeQur Simplicity, Kerendia, TWIIST, Korlym, Omnipod, EVENITY, t:slim X2 Insulin Pump with Control-IQ, Tymlos.
Industry payments across NC — which companies pay providers there.
